January 7, 2026 · Form 4 insider transaction
Bodenstedt Matthias bought 354,296 shares of MOONLAKE THERAPEUTICS at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents shares of restricted stock that vest in four equal annual installments on January 7, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.